Target intelligence / Profile preview

RNA, U6 small nuclear 826, pseudogene (RNU6-826P)

Target
RNU6-826P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 826, pseudogene (RNU6-826P) is classified as a non-coding RNA pseudogene derived from the U6 small nuclear RNA family. U6 snRNA genes typically encode the RNA component of spliceosomal U6 snRNP, an essential catalytic participant in pre-mRNA splicing in eukaryotes[1][3]. However, the "pseudogene" designation indicates that RNU6-826P lacks the capacity to produce a functional U6 snRNA molecule, usually due to sequence mutations, insertions, or deletions that disrupt normal transcription or processing[4]. Pseudogenes can sometimes possess regulatory functions—such as acting as decoys for microRNAs, producing regulatory non-coding RNAs, or influencing their parental gene via epigenetic mechanisms—but there is no specific evidence that RNU6-826P has any such role[2]. It is not considered a receptor, enzyme, transporter, transcription factor, or other classical therapeutic target.

Other names
RNU6-826P
02

Biological functions

Other (No known direct function; pseudogenes can sometimes regulate genetic/epigenetic processes, but not all pseudogenes have defined biological activity[2])
03

Disease associations

Other (General pseudogene roles in disease are documented, but no specific evidence for RNU6-826P involvement[2])

Beyond the preview

Go deeper on RNA, U6 small nuclear 826, pseudogene (RNU6-826P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 826, pseudogene (RNU6-826P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call